{"schema_version":"1","generated_at":"2026-11-18T02:51:16.311Z","data_as_of":"2026-11-12","url":"https://www.findmykol.com/kol/john-reynolds","json_url":"https://www.findmykol.com/kol/john-reynolds/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"john-reynolds","name":"John Reynolds","credential":"MD","title":"Consultant General Surgeon","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Gastrointestinal","therapeutic_areas":["Gastrointestinal","Oncology"],"institution":"Beacon Hospital","institution_url":"https://www.findmykol.com/institution/beacon-hospital","city":"Bismarck","state":"ND","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1417027988"},"summary":"John Reynolds is Consultant General Surgeon at Beacon Hospital. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"John Reynolds, MD, is Consultant General Surgeon at Beacon Hospital, Dublin. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 17 companies.","bullets":["Top research focus: Esophageal Neoplasms","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 17 companies"],"generated_at":"2026-11-17"},"focus":{"indications":[{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Esophageal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Esophageal Squamous Cell Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Esophageal Neoplasms","Gastroesophageal Cancer","Stomach Neoplasms","Duodenal Neoplasms","Pancreatic Cancer"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Opdivo","generic":"Nivolumab","trials":0,"payments":5,"publications":0,"mentions":5},{"name":"Enhertu","generic":"Trastuzumab","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Imbruvica","generic":"Ibrutinib","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":21,"shown":3,"withheld":18,"rows":[{"name":"E.R. Squibb & Sons, L.L.C.","trials":0,"payments":6,"mentions":6},{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":3,"mentions":3},{"name":"Myriad Genetic Laboratories, Inc.","trials":0,"payments":3,"mentions":3}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07417787","title":"Point of Care Tests in the Management of Very Early Medical Abortion","status":"RECRUITING","role":"Investigator","sponsor":"University of Edinburgh","source_url":"https://clinicaltrials.gov/study/NCT07417787","trial_url":"https://www.findmykol.com/trial/NCT07417787"},{"nct":"NCT04654975","title":"Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)","status":"UNKNOWN","role":"Investigator","sponsor":"Universitaire Ziekenhuizen KU Leuven","source_url":"https://clinicaltrials.gov/study/NCT04654975","trial_url":"https://www.findmykol.com/trial/NCT04654975"},{"nct":"NCT04460352","title":"Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Karolinska University Hospital","source_url":"https://clinicaltrials.gov/study/NCT04460352","trial_url":"https://www.findmykol.com/trial/NCT04460352"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":2025},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"Celgene Corporation","program_year":2025,"amount_usd":101.2,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417027988"},{"payer":"Celgene Corporation","program_year":2024,"amount_usd":128.07,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417027988"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2023,"amount_usd":228.01,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417027988"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417027988","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":2,"classes":[{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":62.9,"drugs":[{"name":"Xtandi","share_pct":100}],"max_beneficiaries":13},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":37.1,"drugs":[{"name":"Anastrozole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":0,"rows_total":63,"shown":3,"withheld":60,"rows":[{"project":"U01NS139877","title":"Optimization of Transparent Microelectrode Arrays for Large-scale Multimodal Monitoring of Neural Activity","fiscal_year":2026,"amount_usd":1221187,"organization":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","source_url":"https://reporter.nih.gov/quickSearch/U01NS139877"},{"project":"R01EY028723","title":"Spatiotemporal patterns of neural activity and their role in perception","fiscal_year":2026,"amount_usd":459019,"organization":"SALK INSTITUTE FOR BIOLOGICAL STUDIES","source_url":"https://reporter.nih.gov/quickSearch/R01EY028723"},{"project":"U01NS131914","title":"Traveling Waves in Neocortical Circuits: Mechanisms, Computational Roles in Sensory Processing, and Impact on Sensory Perception","fiscal_year":2025,"amount_usd":1743895,"organization":"SALK INSTITUTE FOR BIOLOGICAL STUDIES","source_url":"https://reporter.nih.gov/quickSearch/U01NS131914"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"awards":{"total":1,"shown":1,"rows":[{"value":"Board Member, Oesophageal Cancer Fund","source_url":"https://www.facebook.com/OesophagealCancerFund/videos/prof-john-reynolds-ocf-board-member-this-oesophageal-cancer-awareness-month-know/2074274766763997/","status":"provisional","collected_at":"2026-11-12"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Guest, The Oesophageal Cancer & Barrett's Oesophagus Podcast","source_url":"https://open.spotify.com/show/7Lbt1aFBiHNXRb1TmmdK5H","status":"provisional","collected_at":"2026-11-12"},{"value":"Subject of Irish Times feature on oesophageal cancer treatment","source_url":"https://www.irishtimes.com/health/your-family/2026/10/06/treating-oesophageal-cancer-the-service-delivered-here-is-on-par-with-the-best-in-the-world/","status":"provisional","collected_at":"2026-11-12"}]}},"similar":[{"name":"Eric Van Cutsem","slug":"eric-cutsem","institution":"University Hospitals Leuven (UZ Leuven)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-cutsem","json_url":"https://www.findmykol.com/kol/eric-cutsem/profile.json"},{"name":"Josep Tabernero","slug":"josep-tabernero","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/josep-tabernero","json_url":"https://www.findmykol.com/kol/josep-tabernero/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Charles Fuchs","slug":"charles-fuchs","institution":"Tubulis GmbH","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/charles-fuchs","json_url":"https://www.findmykol.com/kol/charles-fuchs/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":20,"funding":60}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-12"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-12"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}